Inventor
HARWIG CURTIS
CA32 patents
⚠️ This page may combine multiple inventors who share the name “HARWIG CURTIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ANORMED INC
8 patentsUS6750348B1Jun 15, 2004
Chemokine receptor binding heterocyclic compounds
ANORMED INC61 citations96
US6864265B2Mar 8, 2005
Chemokine receptor binding heterocyclic compounds
ANORMED INC42 citations95
US6835731B2Dec 28, 2004
Chemokine receptor binding heterocyclic compounds
ANORMED INC53 citations95
US7354934B2Apr 8, 2008
Chemokine receptor binding heterocyclic compounds with enhanced efficacy
ANORMED INC34 citations92
US7354932B2Apr 8, 2008
Chemokine receptor binding heterocyclic compounds with enhanced efficacy
ANORMED INC27 citations92
US7091217B2Aug 15, 2006
Chemokine receptor binding heterocyclic compounds
ANORMED INC31 citations92
US6734191B2May 11, 2004
Chemokine receptor binding heterocyclic compounds
ANORMED INC35 citations92
US7183273B2Feb 27, 2007
Chemokine receptor binding heterocyclic compounds
ANORMED INC2 citations62
GENZYME CORP
8 patentsUS7291631B2Nov 6, 2007
CXCR4 chemokine receptor binding compounds
GENZYME CORP50 citations95
US7863293B2Jan 4, 2011
CXCR4 chemokine receptor binding compounds
GENZYME CORP24 citations92
US7550484B2Jun 23, 2009
Chemokine receptor binding heterocyclic compounds with enhanced efficacy
GENZYME CORP19 citations83
US10322111B2Jun 18, 2019
Chemokine receptor binding heterocyclic compounds with enhanced efficacy
GENZYME CORP1 citations71
US7396840B2Jul 8, 2008
Chemokine receptor binding heterocyclic compounds
GENZYME CORP1 citations62
US7629337B2Dec 8, 2009
Chemokine receptor binding heterocyclic compounds
GENZYME CORP1 citations52
US7807694B2Oct 5, 2010
Chemokine receptor binding heterocyclic compounds
GENZYME CORP0 citations51
US7790747B2Sep 7, 2010
Chemokine receptor binding compounds
GENZYME CORP0 citations40
AQUINOX PHARMACEUTICALS CANADA INC
7 patentsUS10174046B2Jan 8, 2019
SHIP1 modulators and methods related thereto
AQUINOX PHARMACEUTICALS CANADA INC0 citations50
US10100056B2Oct 16, 2018
SHIP1 modulators and methods related thereto
AQUINOX PHARMACEUTICALS CANADA INC1 citations50
US10065920B2Sep 4, 2018
Crystalline solid forms of the acetate salt of (1S,3S,4R)-4-((3AS,4R,5S,7AS)-4-(aminomethyl)-7A-methyl-1-methyleneoctahydro-1H-inden-5-YL)-3- (hydroxymethyl)-4-methylcyclohexanol
AQUINOX PHARMACEUTICALS CANADA INC0 citations50
US9944590B2Apr 17, 2018
Crystalline solid forms of the acetate salt of (1S,3S,4R)-4-((3aS,4R,5S,7aS)-4-(aminomethyl)-7a-methyl-1-methyleneoctahydro-1H-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexanol
AQUINOX PHARMACEUTICALS CANADA INC0 citations50
US10272081B2Apr 30, 2019
SHIP1 modulators and methods related thereto
AQUINOX PHARMACEUTICALS CANADA INC0 citations49
US9937167B2Apr 10, 2018
SHIP1 modulators and methods related thereto
AQUINOX PHARMACEUTICALS CANADA INC0 citations49
US10053415B2Aug 21, 2018
Synthesis of a substituted indene derivative
AQUINOX PHARMACEUTICALS CANADA INC0 citations33
TARO PHARMACEUTICALS INC
3 patentsUS11352367B2Jun 7, 2022
Indene derivatives useful in treating pain and inflammation
TARO PHARMACEUTICALS INC2 citations65
US11773108B2Oct 3, 2023
Indene derivatives useful in treating pain and inflammation
TARO PHARMACEUTICALS INC0 citations54
US11420962B2Aug 23, 2022
Indene derivatives useful in treating pain and inflammation
TARO PHARMACEUTICALS INC0 citations42